WDR53 Antibodies

Santa Cruz Biotechnology delivers a wide array of WDR53 monoclonal antibodies for research applications. WDR53 monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). WDR53, or WD repeat domain 53, plays a critical role in cellular processes such as DNA damage response and cell cycle regulation. The function of WDR53 is essential for maintaining genomic stability and proper cellular function, making it a significant target for studies related to cancer and other diseases. Understanding WDR53 can provide insights into therapeutic strategies and potential biomarkers for various conditions. WDR53 monoclonal antibodies enable researchers to investigate cellular pathways and molecular mechanisms involved in disease progression. Studying WDR53 expression patterns and interactions helps advance knowledge in cancer biology and cellular regulation. WDR53 monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.